| Improving engraftment and immune reconstitution in umbilical cord blood transplantation R Danby, V Rocha Frontiers in immunology 5, 68, 2014 | 171 | 2014 |
| Molecular MRD status and outcome after transplantation in NPM1-mutated AML R Dillon, R Hills, S Freeman, N Potter, J Jovanovic, A Ivey, AS Kanda, ... Blood, The Journal of the American Society of Hematology 135 (9), 680-688, 2020 | 151 | 2020 |
| Haematopoietic stem cell transplants: principles and indications K Balassa, R Danby, V Rocha British Journal of Hospital Medicine 80 (1), 33-39, 2019 | 143 | 2019 |
| Recipients receiving better HLA-matched hematopoietic cell transplantation grafts, uncovered by a novel HLA typing method, have superior survival: a retrospective study NP Mayor, JD Hayhurst, TR Turner, RM Szydlo, BE Shaw, WP Bultitude, ... Biology of Blood and Marrow Transplantation 25 (3), 443-450, 2019 | 116 | 2019 |
| Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection … R Hough, R Danby, N Russell, D Marks, P Veys, B Shaw, R Wynn, A Vora, ... British Journal of Haematology 172 (3), 360-370, 2016 | 111 | 2016 |
| Clinical Grade Regulatory CD4+ T Cells (Tregs): Moving Toward Cellular-Based Immunomodulatory Therapies R Duggleby, RD Danby, JA Madrigal, A Saudemont Frontiers in immunology 9, 252, 2018 | 87 | 2018 |
| Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia L Quek, P Ferguson, M Metzner, I Ahmed, A Kennedy, C Garnett, ... Blood Advances 1 (3), 193-204, 2016 | 74 | 2016 |
| Increased regulatory T cell graft content is associated with improved outcome in haematopoietic stem cell transplantation: a systematic review SA Fisher, A Lamikanra, C Doree, B Gration, P Tsang, RD Danby, ... British journal of haematology 176 (3), 448-463, 2017 | 47 | 2017 |
| High proportions of regulatory T cells in PBSC grafts predict improved survival after allogeneic haematopoietic SCT RD Danby, W Zhang, P Medd, TJ Littlewood, A Peniket, V Rocha, ... Bone marrow transplantation 51 (1), 110-118, 2016 | 42 | 2016 |
| Killer cell immunoglobulin-like receptor–ligand matching and outcomes after unrelated cord blood transplantation in acute myeloid leukemia V Rocha, A Ruggeri, S Spellman, T Wang, R Sobecks, F Locatelli, ... Biology of Blood and Marrow Transplantation 22 (7), 1284-1289, 2016 | 34 | 2016 |
| Nanopore metagenomic sequencing to investigate nosocomial transmission of human metapneumovirus from a unique genetic group among haematology patients in the United Kingdom Y Xu, K Lewandowski, K Jeffery, LO Downs, D Foster, ND Sanderson, ... Journal of Infection 80 (5), 571-577, 2020 | 28 | 2020 |
| Transfusion in CMV seronegative T‐depleted allogeneic stem cell transplant recipients with CMV‐unselected blood components results in zero CMV transmissions in the era of … S Hall, R Danby, H Osman, A Peniket, V Rocha, C Craddock, M Murphy, ... Transfusion Medicine 25 (6), 418-423, 2015 | 25 | 2015 |
| “Is this the GVHD?” A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their … I de Vere Hunt, JM Kilgour, R Danby, A Peniket, RN Matin Health and Quality of Life Outcomes 19, 1-17, 2021 | 20 | 2021 |
| Impaired humoral and cellular response to primary COVID‐19 vaccination in patients less than 2 years after allogeneic bone marrow transplant SM Murray, M Barbanti, C Campbell, A Brown, L Chen, J Dhanapal, ... British Journal of Haematology 198 (4), 668-679, 2022 | 18 | 2022 |
| Functional characterisation and analysis of the soluble NKG2D ligand repertoire detected in umbilical cord blood plasma ST Cox, R Danby, D Hernandez, R Laza-Briviesca, H Pearson, ... Frontiers in immunology 9, 1282, 2018 | 15 | 2018 |
| A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings? DRA Silveira, JL Coelho-Silva, WF Silva, G Vallance, DA Pereira-Martins, ... Leukemia & Lymphoma 62 (1), 147-157, 2021 | 11 | 2021 |
| Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation K Balassa, R Salisbury, E Watson, M Lubowiecki, B Tseu, N Maouche, ... Journal of Infection 78 (6), 461-467, 2019 | 11 | 2019 |
| Transfusion of CMV‐unselected blood components may lead to inappropriate donor selection for patients subsequently undergoing allogeneic stem cell transplant S Morton, R Danby, V Rocha, A Peniket, MF Murphy Transfusion Medicine 25 (6), 411-413, 2015 | 11 | 2015 |
| Impact of graft‐versus‐lymphoma effect on outcomes after reduced intensity conditioned‐alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature … CK Brierley, FM Jones, K Hanlon, AJ Peniket, C Hatton, GP Collins, ... British journal of haematology 184 (4), 547-557, 2019 | 10 | 2019 |
| Better HLA matching as revealed only by next generation sequencing technology results in superior overall survival post-allogeneic haematopoietic cell transplantation with … NP Mayor, JD Hayhurst, TR Turner, RM Szydlo, BE Shaw, WP Bultitude, ... Biology of Blood and Marrow Transplantation 24 (3), S63-S64, 2018 | 10 | 2018 |
